Insights from the Latest Study: Single-use Biomanufacturing Industry 2022-2030
Single-use Biomanufacturing Industry | Forecast 2030
Single-use Biomanufacturing Industry Data Book - Single-Use Bioprocessing, Bioreactor, Assemblies & Filtration Assemblies Market
Grand View Research’s Single-use Biomanufacturing Industry data book is a collection of market sizing & forecasts insights, market dynamics & trends, opportunity assessment, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, and macro-environmental analyses studies. Within the purview of the data book, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.
Single-Use Biomanufacturing Industry Data Book Coverage Snapshot
Markets Covered
- Single-Use Bioprocessing Market Size USD 19.36 billion in 2021, 16.6% CAGR (2022-2030)
- Single-use Assemblies Market Size USD 8.37 billion in 2021, 18.57% CAGR (2022-2030)
- Single-use Bioreactor Market Size USD 2.73 billion in 2021, 17.6% CAGR (2022-2030)
- Single-use Filtration Assemblies Market Size USD 2.43 billion in 2021, 18.7% CAGR (2022-2030)
Access the Global Single-use Biomanufacturing Industry Data Book, 2022 to 2030, compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental analyses, and regulatory & technological framework studies
Single-use Bioprocessing Market Growth & Trends
The global single-use bioprocessing market size is projected to reach USD 80,129 million by 2030, registering a compound annual growth rate (CAGR) of 16.24% over the forecast period, according to a new report by Grand View Research, Inc. The demand for single-use bioprocessing offerings is driven by the commercial advantages offered, including a reduction in costs and time required for bioprocessing operations. Originally used for monoclonal antibody production, single-use technologies are also gaining traction for cell and gene therapy manufacturing. As a result, broadening the scope of applications in biomanufacturing operations is likely to drive industry growth.
Furthermore, strategic initiatives from key players are expanding the industry's growth prospects. For instance, in July 2021, Cytiva and Pall Corp. announced investment plans for capacity expansion over two years. Among other key products, more than USD 300 million were invested in single-use technologies, such as bioreactor bags for cell expansion, used to make personalized therapies and syringe filters for scientific research. Similarly, the growing adoption of single-use equipment for in-house and contract manufacturing has opened new avenues for the flow of investments in this space. The industry is witnessing significant advancements in several product portfolios, including disposable probes and sensors, stirring systems, bioreactor designs, and filtration technologies, which are expected to contribute to strong revenue growth.
Order your copy of the Free Sample of “Single-use Biomanufacturing Industry Data Book - Single-Use Bioprocessing, Bioreactor, Assemblies & Filtration Assemblies Market Size, Share, Trends Analysis, And Segment Forecasts, 2022 - 2030” Data Book, published by Grand View Research
Single-use Assemblies Market Growth & Trends
The global single-use assemblies market size is expected to reach USD 39.96 billion by 2030, registering a CAGR of 18.60% during the forecast period, according to a new report by Grand View Research, Inc. Life science companies are eager to avoid the cost and time of cleaning needed with stainless steel. The augmented expansion of the international biotech industries has offered a growth environment, in which novel, disposable technologies are becoming more significant. As pharmaceutical companies, distributors, CDMOs, and manufacturers converge around the benefits of single-use assemblies, the industry will grow at a faster pace during the forecast period. From therapies for rare diseases to cancer research, the impact of single-use technology in accelerating cutting-edge research into these conditions is set to grow, thereby propelling industry growth.
In addition, the growing biologics market will further offer lucrative opportunities during the study period. Eradicating the risk of contamination is the major challenge faced by biopharmaceutical manufacturers, which currently involves high-level monitoring of critical manufacturing solutions. Single-use assemblies support manufacturers in overcoming this difficulty by eliminating or reducing the necessity for sterilization between the batches, thereby filtering the operational capability. SUTs are considered one of the important areas of growth among biomanufacturing companies, as several biopharmaceutical companies are venturing into disposable assembly offerings for the production of all sorts of biopharmaceuticals.
Go through the table of content of Single-use Biomanufacturing Industry Data Book to get a better understanding of the Coverage & Scope of the study
Single-use Filtration Assemblies Market Growth & Trends
The global single-use filtration assemblies market size is expected to reach USD 11.8 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 18.70% from 2023 to 2030. The increasing demand for biopharmaceutical products, rising research and development activities, and the need for cost-effective filtration systems are the major drivers of the market. The biopharmaceutical industry is growing rapidly, with an increasing number of companies investing in R&D to bring new drugs and therapies to market. Biopharmaceutical products are sensitive to contaminants, which can affect their efficacy and safety.
Therefore, biopharmaceutical companies require high-quality filtration systems that can remove impurities and contaminants from their products. Single-use filtration assemblies offer several advantages over traditional filtration systems, such as reduced contamination risk, lower capital costs, and increased flexibility. As a result, the adoption of single-use filtration assemblies is increasing in the biopharmaceutical industry, which is expected to boost the industry growth during the forecast period.
Competitive Landscape
Competitive rivalry in the single-use bioprocessing market is high due to the presence of a substantial number of both well-established companies and small- to mid-sized companies as well as CROs in the industry. Some of the major players are Thermo Fisher Scientific, Inc.; Sartorius AG; Corning, Inc.; Eppendorf AG; PBS Biotech, Inc.; Avantor, Inc.; Entegris, Inc.; Kuhner AG; MEISSNER FILTRATION PRODUCTS, INC.; Danaher Corporation; and Merck KGaA. Some of the biopharmaceutical contract manufacturing companies operating in the marketplace include Boehringer Ingelheim; Lonza; AGC Biologics (CMC Biologics); and Rentschler Biotechnologie GmbH. These players are manufacturing and commercializing products to cater to the various requirements in the industry. To maintain a significant share of the market, key participants are implementing business strategies, such as broadening their product portfolio, reinforcing and stabilizing the distribution network, and increasing manufacturing capacity globally through collaborations, partnerships, and acquisition models.
Check out more Industry Data Books, published by Grand View Research
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Comments
Post a Comment